We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a before-and-after study to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use A/B testing to evaluate your digital health product.
Check what you need to do to sell cosmetic products in Great Britain.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Information on comparator products used in studies supporting abridged marketing authorisation application.
Compare different evaluation approaches and choose an appropriate method.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use an economic evaluation to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).